Clinical Trial Update: Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics [Phase 4]

View source ↗

Summary

Phase 4 trial investigating protease inhibitors and combined oral contraceptive pharmacokinetics/pharmacodynamics was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception
• HIV Infection

Snippet

Sponsor: University of Southern California | Conditions: Contraception, HIV | Phase 4 | Status: TERMINATED | Results posted: 2019-05-31